System Xc− inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance
-
Published:2022-06
Issue:
Volume:535
Page:215649
-
ISSN:0304-3835
-
Container-title:Cancer Letters
-
language:en
-
Short-container-title:Cancer Letters
Author:
Wang FangORCID,
Oudaert IngeORCID,
Tu Chenggong,
Maes Anke,
Van der Vreken Arne,
Vlummens Philip,
De Bruyne Elke,
De Veirman Kim,
Wang YanmengORCID,
Fan Rong,
Massie AnnORCID,
Vanderkerken Karin,
Shang Peng,
Menu ElineORCID
Subject
Cancer Research,Oncology
Reference37 articles.
1. Multiple myeloma;Palumbo;N. Engl. J. Med.,2011
2. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy;Kane;Oncol.,2003
3. Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance;Nikesitch;Clin. Transl. Immunol.,2018
4. The biology, function, and biomedical applications of exosomes;Kalluri;Science,2020
5. Extracellular microvesicles/exosomes: discovery, disbelief, acceptance, and the future?;Ratajczak;Leukemia,2020
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献